实时连续血糖监测对胰岛素泵治疗1型糖尿病成人患者的持续影响:RESCUE研究24个月结果
结果显示24个月后HbA1c较基线显著降低,低血糖恐惧评分和低血糖相关急性并发症持续改善,尤其低血糖感知受损者严重低血糖事件大幅减少。
要点
- rtCGM使用24个月后HbA1c较基线持续降低(7.64% vs 7.37%)。
- 低血糖感知受损者严重低血糖事件从第一年862例降至第二年每100患者年119例。
- HbA1c<7%且无严重低血糖事件者比例从11.0%增至25.4%。
核心结论
- 使用rtCGM可在24个月内持续改善低血糖相关血糖控制,降低低血糖恐惧、急性低血糖事件及糖尿病相关缺勤,尤其对低血糖感知受损者获益最大。
主要发现
- 24个月后HbA1c较基线显著降低(7.64% [60 mmol/mol] vs 7.37% [57 mmol/mol],P<0.0001)。
- 低血糖恐惧调查评分和低血糖相关急性并发症持续改善,且不依赖于低血糖感知水平。
- 低血糖感知受损者改善最显著,严重低血糖事件从第一年862例降至第二年每100患者年119例(P<0.0001)。
- 24个月内达到低血糖共识目标者增多,达到高血糖共识目标者略减少。
- HbA1c<7%(<53 mmol/mol)且无严重低血糖事件者比例从11.0%增至25.4%(P<0.0001)。
关键数值与推荐
- 24个月时HbA1c为7.37% [57 mmol/mol],基线为7.64% [60 mmol/mol](P<0.0001)。
- 低血糖感知受损者严重低血糖事件:第一年862例 vs 第二年每100患者年119例(P<0.0001)。
- HbA1c<7%(<53 mmol/mol)且无严重低血糖事件者比例:11.0% vs 25.4%(P<0.0001)。
临床怎么用
- 对使用胰岛素泵的1型糖尿病成人,尤其合并低血糖感知受损者,可考虑长期使用rtCGM以持续改善低血糖相关结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In recent years, a growing number of people with type 1 diabetes gained access to real-time continuous glucose monitoring (rtCGM). Long-term benefits of rtCGM are unclear because of a lack of large studies of long duration. We evaluated whether real-world rtCGM use up to 24 months offered benefits, particularly in those living with impaired awareness of hypoglycemia (IAH). RESEARCH DESIGN AND METHODS: This 24-month, prospective, observational cohort study followed 441 adults with insulin pumps receiving full reimbursement for rtCGM. Forty-two percent had IAH. The primary end point was evolution of HbA1c, with secondary end points change in acute hypoglycemia complications, diabetes-related work absenteeism, and quality of life scores. Additionally, we evaluated whether people could achieve glycemic consensus targets during follow-up. RESULTS: After 24 months, HbA1c remained significantly lower compared with baseline (7.64% [60 mmol/mol] vs. 7.37% [57 mmol/mol], P < 0.0001). Sustained benefits were also observed for the score on the hypoglycemia fear survey and hypoglycemia-related acute complications irrespective of hypoglycemia awareness level. People with IAH had the strongest improvement, especially for severe hypoglycemia (862 events in the year before vs. 119 events per 100 patient-years in the 2nd year, P < 0.0001). Over 24 months, more people were able to meet hypoglycemia consensus targets at the expense of slightly fewer people achieving hyperglycemia consensus targets. Furthermore, the number of people with HbA1c <7% (<53 mmol/mol) without severe hypoglycemia events more than doubled (11.0% vs. 25.4%, P < 0.0001). CONCLUSIONS: Use of rtCGM led to sustained improvements in hypoglycemia-related glucose control over 24 months. Lower fear of hypoglycemia, fewer acute hypoglycemia-related events, and fewer diabetes-related days off from work were observed, particularly in those with IAH.
引用
- Charleer S, De Block C, Nobels F, et al. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study. Diabetes Care. 2020. PMID: 33067260. doi:10.2337/dc20-1531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。